327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor

327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor

Bibliographic Details
Main Authors: Jian Shi, Junyan Wang, Baoen Shan, Jiayin Liu, Rongfeng Liu, Yujie Shan
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-aa3eae277c5e49e78d8af69d86aa3040
record_format Article
spelling doaj-aa3eae277c5e49e78d8af69d86aa30402020-12-11T10:04:44ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0327327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumorJian Shi0Junyan Wang1Baoen Shan2Jiayin Liu3Rongfeng Liu4Yujie Shan5Aff1 grid.21925.3d0000000419369000Department of MedicineUniversity of Pittsburgh Pittsburgh PA USA Center for Disease Control, Minhang, Shanghai 201105, ChinaFourth Hospital of Hebei Medical University, shijiazhuang, ChinaFourth Hospital of Hebei Medical University, shijiazhuang, ChinaFourth Hospital of Hebei Medical University, shijiazhuang, ChinaFourth Hospital of Hebei Medical University, shijiazhuang, China
collection DOAJ
language English
format Article
sources DOAJ
author Jian Shi
Junyan Wang
Baoen Shan
Jiayin Liu
Rongfeng Liu
Yujie Shan
spellingShingle Jian Shi
Junyan Wang
Baoen Shan
Jiayin Liu
Rongfeng Liu
Yujie Shan
327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
Journal for ImmunoTherapy of Cancer
author_facet Jian Shi
Junyan Wang
Baoen Shan
Jiayin Liu
Rongfeng Liu
Yujie Shan
author_sort Jian Shi
title 327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
title_short 327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
title_full 327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
title_fullStr 327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
title_full_unstemmed 327 Study of anti-PD-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
title_sort 327 study of anti-pd-1 antibody multimodal combination as first-line treatment on time window of advanced solid tumor
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT jianshi 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
AT junyanwang 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
AT baoenshan 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
AT jiayinliu 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
AT rongfengliu 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
AT yujieshan 327studyofantipd1antibodymultimodalcombinationasfirstlinetreatmentontimewindowofadvancedsolidtumor
_version_ 1724386480606937088

Similar Items